Learn how machine learning and digital microscopy come together as an innovative method for studying phenotypic response of individual live cells and microcolonies.
Creating. Innovating. Collaborating. We move quickly at Accelerate by removing much of the bureaucracy that can stifle progress. Experience what its like to work here and see current career opportunities.
Presentations & Press Releases
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the release of positive results from three clinical studies on the Accelerate Pheno™ system that will be presented at IDWeek™ 2019....
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Jack Phillips has been appointed Chief Operating Officer. Mr. Phillips joins Accelerate from Roche Diagnostics, the world's leading...
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2019. "We achieved mixed results in the second quarter, as revenue and...
View all press releases
View all events
Join our mailing list
Morgan Stanley Global Healthcare Conference
These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.
Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.
See product labeling for instructions for use, warnings, and limitations specific to each product and region.
No thanks. Please take me back.